Insider Insights
24.07.2023
Johnson & Johnson sue the US government

J&J sues US government, alleging infringement on First Amendment rights and unfair drug pricing unde...

Read more
Insider Insights
16.06.2023
MMPI report states possibility for £15 billion in...

MMIP report suggests a boost in UK medicines manufacturing could result in £15 billion investments ...

Read more
Insider Insights
13.06.2023
Collaboration proposes a new method for combinatio...

In a joint report Lif, the New Therapeutics (NT) Council and representatives of the regions have pro...

Read more
Insider Insights
12.06.2023
CMS sets inflation penalties on 43 drugs

In a move towards curbing rising drug prices, the Inflation Reduction Act (IRA) provision will impos...

Read more
Insider Insights
05.05.2023
HAS issues favorable reimbursement opinion

This is the first time that HAS is issuing a favorable opinion for the reimbursement of a technology...

Read more
Insider Insights
04.05.2023
NICE collaborates with international partner agenc...

UK, Canada and United States join forces to streamline process and increase transparency for confide...

Read more
Insider Insights
28.04.2023
The EU Pharmaceutical package missed the mark in t...

EFPIA and VFA bosses state their concerns that the newly released EU Pharmaceutical Laws will furthe...

Read more
Insider Insights
27.04.2023
The European Commission publish their proposal for...

The European Commission has published their proposal for revised pharmaceutical legislation to cover...

Read more
Insider Insights
25.04.2023
The Nordic Pharmaceutical Forum strengthens its co...

The Nordic Pharmaceutical Forum's new joint strategy focuses on innovative procurement cooperation a...

Read more
Insider Insights
25.04.2023
EU aims to revamp European pharmaceutical laws

With country health budgets drained following the pandemic, the European Commission aims to reform E...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.